Smarter radiation aims to outsmart pancreatic cancer
NCT ID NCT04699539
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tested whether a new way of targeting radiation (based on where the cancer usually comes back) works better than the standard method for locally advanced pancreatic cancer. 96 patients received either the new or standard radiation. The study looked at how long patients lived without the cancer growing and overall survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (stereotactic body radiation therapy, SBRT)
What this could lead to
If successful, this could lead to a more effective way to target radiation for pancreatic cancer, potentially improving survival without increasing side effects.
What could go wrong
This is a small, early-phase trial (96 people) and results may not apply to all patients. The new approach may not improve outcomes and could cause more side effects due to larger radiation fields.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changhai hospital
Shanghai, Shanghai Municipality, 200433, China